Drugmaker Swedish Orphan Biovitrum said on Saturday it had agreed to acquire U.S.-based biotechnology company Arthrosi Therapeutics for up to $1.5 billion to strengthen its portfolio of gout...
Sweden's Sobi to buy US biotech Arthrosi for up to $1.5 billion to boost gout pipeline
